Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun:161:209289.
doi: 10.1016/j.josat.2024.209289. Epub 2024 Jan 24.

Timing of treatment for opioid use disorder among birthing people

Kyungha Kim  1 , Guodong Liu  2 , Andrew W Dick  3 , Sung W Choi  4 , Edeanya Agbese  2 , Tammy E Corr  5 , Charleen Hsuan  6 , Megan S Wright  7 , Sujeong Park  4 , Diana Velott  2 , Douglas L Leslie  2
Affiliations

Timing of treatment for opioid use disorder among birthing people

Kyungha Kim et al. J Subst Use Addict Treat. 2024 Jun.

Abstract

Background: The number of pregnant women with opioid use disorder (OUD) has increased over time. Although effective treatment options exist, little is known about the extent to which women receive treatment during pregnancy and at what stage of pregnancy care is initiated.

Methods: Using a national private health insurance claims database, we identified women aged 13-49 who gave birth in 2006-2019 and had an OUD or nonfatal opioid overdose (NFOO) diagnosis during the year prior to or at delivery. We then identified women who received their first OUD treatment prior to or during pregnancy. In this cross-sectional study, we investigated how rates and timing of the initial OUD treatment changed over time. Furthermore, we examined factors associated with early initiation of OUD treatment among birthing people.

Results: Of the 7057 deliveries from 6747 women with OUD or NFOO, 63.3 % received any OUD treatment. Rates of OUD treatment increased from 42.9 % in 2006 to 69 % in 2019. Of those treated, in 2006, 54.5 % received their first treatment prior to conception and 24.2 % initiated care during the 1st trimester. In 2019, 68.9 % received their first treatment prior to conception, and 15.1 % initiated care during the 1st trimester. The percentage of women who were first treated in the 2nd trimester or later decreased from 21.2 % in 2006 to 16.1 % in 2019. Factors associated with early treatment initiation include being 25 years or older (age 25-34: aOR, 1.51, 95 % CI, 1.28-1.78; age 35-49: aOR, 1.82, 95 % CI, 1.39-2.37), living in urban areas (aOR, 1.28; 95 % CI, 1.05-1.56), having pre-existing behavioral health comorbidities such as anxiety disorders (aOR, 1.8; 95 % CI, 1.40-2.32), mood disorders (aOR, 1.63; 95 % CI, 1.02-2.61), and substance use disorder other than OUD (aOR, 2.56; 95 % CI, 2.03-3.32).

Conclusion: Overall, rates of OUD treatment increased over time, and more women initiated OUD treatment prior to conception. Despite these improvements, over one-third of pregnant women with OUD/NFOO either received no treatment or did not initiate care until the 3rd trimester in 2019. Future research should examine barriers to OUD treatment initiation among pregnant women.

Keywords: Buprenorphine; Medication for Opioid Use Disorder (MOUD); Opioid use disorder (OUD); Pregnancy; Timing of OUD treatment initiation.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None.

Figures

Fig. 1.
Fig. 1.
Rates of opioid use disorder (OUD) treatment.
Fig. 2.
Fig. 2.
Timing of OUD treatment initiation.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Abraham AJ, Andrews CM, Harris SJ, Westlake MM, & Grogan CM (2022). Coverage and prior authorization policies for medications for opioid use disorder in Medicaid managed care. JAMA Health Forum, 3(11), e224001. - PMC - PubMed
    1. ACOG Committee on Health Care for Underserved Women and American Society of Addiction and Medicine. (2012). ACOG Committee opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstetrics and Gynecology, 119(5), 1070–1076. - PubMed
    1. Agbese E, Stein BD, Druss BG, Dick AW, Pacula RL, & Leslie DL (2022). Mental health conditions and substance use disorders among youth subsequently diagnosed with opioid use disorder or opioid poisoning. Journal of Addiction Medicine, 16(3), 357–359. - PMC - PubMed
    1. Ailes EC, Simeone RM, Dawson AL, Petersen EE, & Gilboa SM (2016). Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants. Birth Defects Research Part A: Clinical and Molecular Teratology, 106(11), 927–934. - PMC - PubMed
    1. Ayoola AB, Nettleman MD, Stommel M, & Canady RB (2010). Time of pregnancy recognition and prenatal care use: A population-based study in the United States. Birth, 37(1), 37–43. - PubMed